The DNA three-prime repair exonuclease Trex1 (TREX1) is estimated to have a diminishing effect on immunogenicity by degrading accumulated DNA in the cytosol; this could activate the cGAS-STING pathway, which essential for CD8+ T cells that mediate systemic tumor rejection in the context of ICI. Here, TREX1 is linked to neoplasm.